Nov 25, 2016
Commenting on the 2016 Autumn Statement, BIVDA’s Chief Executive Doris-Ann Williams MBE said:
“As the UK looks to establish its new place in the world following the outcome of the EU Referendum, we welcome the Government’s commitment to investment in research and development."
Nov 23, 2016
Cancer Research UK have today (23 November 2016) published a report which finds that UK pathology services are struggling to meet the rising number of patient samples that need to be tested.
Oct 24, 2016
Doris-Ann Williams MBE, Chief Executive of BIVDA, has responded to the publication of the final report of the Accelerated Access Review.
Sep 22, 2016
Doris-Ann Williams MBE, Chief Executive of the British In Vitro Diagnostics Association (BIVDA), represented the IVD industry at the United Nations General Assembly meeting on antimicrobial resistance (AMR) on Wednesday (22 September 2016).
Jul 08, 2016
BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commissioning and funding of six molecular diagnostic tests for cancer in the NHS in England for 2016/17.
Jun 27, 2016
BIVDA has today published a report looking at the findings of its survey of point of care coordinators within secondary care in the UK.
Apr 27, 2016
BIVDA and Diabetes UK are calling for healthcare professionals (HCPs) to take urgent action and check their patients’ blood glucose meter systems for compliance ahead of the implementation of ISO Standard 15197: 2013 in May.
Feb 21, 2016
BIVDA has joined more than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, in coming together to call on governments and industry to work in parallel in taking comprehensive action against drug-resistant infections – so-called ‘superbugs’ – with a joint declaration launched today at the World Economic Forum in Davos, Switzerland.
Jan 20, 2016
A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to develop a national framework for the commissioning of molecular diagnostics.